nach oben

AIDS and Behavior

Erschienen in:

01.05.2006 | HIV Treatment Research Article

Neurocognitive Aspects of Medication Adherence in HIV-Positive Injecting Drug Users

verfasst von: Drenna Waldrop-Valverde, Raymond L. Ownby, Frances L. Wilkie, Alison Mack, Mahendra Kumar, Lisa Metsch

Erschienen in: AIDS and Behavior | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Cognitive deficits are associated with nonadherence to HIV medications. HIV-positive injecting drug users (IDUs) are at particular risk for nonadherence and cognitive barriers to adherence specific to this population should therefore be identified. The present study assessed the relation of three domains of cognitive functioning, executive functions, memory, and psychomotor speed, to self-reported antiretroviral adherence in a sample of HIV-positive IDUs. Depression, use of alcohol, heroin, cocaine/crack, or marijuana in the last week were also included in the models. Logistic regression analyses showed that only psychomotor slowing was significantly associated with nonadherence. Executive functions, memory, depression, and active alcohol and substance use were unrelated to adherence. No other studies to date have exclusively linked psychomotor slowing to nonadherence in HIV infection. Psychomotor slowing among our study sample was severe and suggests that when evident, such slowing may be a valuable determinant for antiretroviral adherence among IDUs.

Ahmad, S., Ahmad, H., and Bindra, G. (1989). Cognitive impairment in chronic heroin addicts. Journal of Personality and Clinical Studies, 5, 237–240.

Albert, S. M., Weber, C. M., Todak, G., Polanco, C., Clouse,R., McElhiney, M., Rabkin, J., Stern, Y., Marder, K.(1999). An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication adherence outcomes. AIDS and Behavior, 3, 121–128.CrossRef

Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevich, M. N., Chang, C., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423.CrossRefPubMed

Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381.CrossRefPubMed

Avants, S. K., Margolin, A., Warburton, L. A., Hawkins, K. A., and Shi, J. (2001). Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. The American Journal on Addictions, 10, 69–78.CrossRefPubMed

Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.CrossRefPubMed

Basso, M. R., and Bornstein, R. A. (2000). Neurobehavioral consequences of substance abuse and HIV infection. Journal of Psychopharmacology, 14, 228–237.PubMedCrossRef

Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., and Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.PubMed

Benton, A. L., Hamsher, K., and Sivan, A. B. (1983). Multilingual Aphasia Examination (3rd ed.). Iowa City, IA: AJA Associates.

Berry, J., van Gorp, W. G., Herzberg, D. S., Hinkin, C., Boone, K., Steinman, L., et al. (1993). Neuropsychological deficits in abstinent cocaine abusers: Preliminary findings after two weeks of abstinence. Drug and Alcohol Dependence, 32, 231–237.CrossRefPubMed

Bono, G., Mauri, M., Sinforiani, E., Barbarini, G., Minoli, L., and Fea, M. (1996). Longitudinal neuropsychological evaluation of HIV-infected intravenous drug users. Addiction, 91, 263–268.CrossRefPubMed

Bornstein, R. A., Pace, P., Rosenberger, P., Nasrallah, H. A., Para, M. F., Whitacre, C. C., et al. (1993). Depression and neuropsychological performance in asymptomatic HIV infection. American Journal of Psychiatry, 150, 922–927.PubMed

Carrieri, M. P., Chesney, M. A., Spire, B., Loundou, A., Sobel, A., Lepeu, G., Moatti, J. P., and the MANIF Study Group. (2003). Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. International Journal of Behavioral Medicine, 10, 1–14.CrossRefPubMed

Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., and McAuliffe, T. L. (2000). Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124–133.CrossRefPubMed

Cohen, R. A., Boland, R., Paul, R., Tashima, K. T., Schoenbaum, E. E., Celentano, D. D., et al. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV infected women. AIDS, 15, 341–345.CrossRefPubMed

Cummings, J. L., and Benson, D. F. (1992). Dementia: A clinical approach (2nd ed.). Boston: Butterworth Heinemann.

The Dana Consortium. (1996). Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology, 47, 1247–1253.

D’Elia, L., Satz, P., Uchiyama, C. L., and White, T. (1996). Color trails 1 and 2. Odessa, FL: Psychological Assessment Resources.

Ferrando, S., van Gorp, W., McElhiney, M., Goggin, K., Sewell, M., and Rabkin, J. (1998). Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function. AIDS, 12, F65–F70.CrossRefPubMed

First, M. B., Spitzer, R. L., Gibbon, M., and Williams, J. B. (1995). Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (Version 2.0). New York: New York State Psychiatric Institute.

Galea, S., and Vlahov, D. (2002). Social determinants and the health of drug users: Socioeconomic status, homeless, and incarceration. Public Health Reports, 117, S135–S145.PubMed

Gordillo, V., del Amo, J., Soriano, V., and Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763–1769.CrossRefPubMed

Grant, I., Adams, K. M., Carlin, A. S., Rennick, P. M., Judd, L. L., Schooff, K., et al. (1978). Neuropsychological effects of polydrug abuse. In D. R. Wesson, A. S. Carlin, K. M. Adams, and G. Beschner (Eds.), Polydrug abuse. The results of a national collaborative study (pp. 223–261). New York: Academic.

Grant, I., Atkinson, J. H., Hesselink, J. R., Kennedy, C. J., Richman, D. D., and Spector, S. A., et al. (1987). Evidence for early central nervous system involvement in the Acquired immunodeficiency virus (HIV) infections. Annals of Internal Medicine, 107, 828–836.PubMed

Grant, I., and Martin, A. (1994). Neurocognitive disorders associated with HIV-1 infection. In I. Grant and A. Martin (Eds.), Neuropsychology of HIV-1 infection (pp. 3–19). New York: Oxford University Press.

Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., and Mason, K. I., et al. (2002). Medication adherence among HIV+ adults. Neurology, 59, 1944–1950.PubMed

Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient, age, cognitive status, and substance abuse. AIDS, 18, S19–S25.CrossRefPubMed

Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., Stone, V. E., Smith, D. K., Schoenbaum, E. E., and the HER Study Group. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175–2182.CrossRefPubMed

Karon, J. M., Fleming, P. L., Steketee, R. W., and DeCock, K. M. (2001). HIV in the United States at the turn of the century. American Journal of Public Health, 91, 1060–1068.PubMedCrossRef

Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanadaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.PubMed

Lucas, G. M., Cheever, L. W., Chaisson, R. E., and Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27, 251–259.PubMed

Mannheimer, S., Friedland, G., Matts, J., Child, C., and Chesney, M. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases, 34, 1115–1121.CrossRefPubMed

Martens, W. H. (2001). A review of physical and mental health in homeless persons. Public Health Review, 29, 13–33.

Meek, P. S., Clark, H. W., and Solana, V. L. (1989). Neurocognitive impairment: The unrecognized component of dual diagnoses in substance abuse treatment. Journal of Psychoactive Drugs, 21, 153–160.PubMed

Montaner, J. S. G., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., et al. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine and zidovudine for HIV-infected patients. JAMA, 279, 930–937.CrossRefPubMed

Murphy, E. L., Collier, A. C., Kalish, L. A., Assmann, S. F., Para, M. F., Flanigan, T. P., et al. (2001). Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Annals of Internal Medicince, 135, 17–26.

Navia, B. A., Jordan, B. D., and Price, R. W. (1986). The AIDS dementia complex: I. Clinical features. Annals of Neurology, 19, 517–524.CrossRefPubMed

Paterson, D., Swindells, S., Mohr, J., Brestor, M., Vergis, R., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed

Paterson, D. L., Potoski, B., and Capitano, B. (2002). Measurement of adherence to antiretroviral medications. Journal of Acquired Immune Deficiency Syndromes, 31, S103–S106.PubMed

Sacktor, N., McDermott, M. P., Marder, K., Schiffito, G., Selnes, O. A., McArthur, J. C., et al. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8, 136–142.CrossRefPubMed

Sacktor, N., Skolasly, R. L., Tarwater, P. M., McArthur, J. C., Selnes, O. A., Becker, J., et al. (2003). Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology, 61, 567–569.PubMed

Sankoh, A. J., Huque, M. F., and Dubey, S. D. (1997). Some comments on frequently used multiple endpoint adjustments methods in clinical trials. Statistics in Medicine, 16, 2529–2542.CrossRefPubMed

Selnes, O. A., Galai, N., McArthur, J. C., Cohn, S., Royal, W., Esposito, D., et al. (1997). HIV infection and cognition in intravenous drug users: Long-term follow-up. Neurology, 48, 223–230.PubMed

Smith, A. (2000). Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services.

Stern, R. A., Silva, S. G., Chaisson, N., and Evans, D. L. (1996). Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Archives of Neurology, 53, 148–153.PubMed

Stevens, J. (1996). Applied Multivariate Statistics for the Social Sciences (3rd ed.). Mahwah, NJ: Erlbaum.

Strickland, T. L., Miller, B. L., Kowell, A., and Stein, R. (1993). Neurobiology of cocaine-induced organic brain impairment: Contribution from functional neuroimaging. Neuropsychology Review, 8, 1–9.CrossRef

Suarez, S., Baril, L., Stankoff, B., Khellaf, M., Dubois, B., Lubetzki, C., et al. (2001). Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. AIDS, 15, 195–200.CrossRefPubMed

Tesoriero, J., French, T., Weiss, L., Waters, M., Finkelstein, R., and Agins, B. (2003). Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. JAIDS: Journal of the Acquired Immune Deficiency Syndromes, 33, 484–493.

Tiffin, J. (1968). Purdue Pegboard: Examiner manual. Chicago: Science Research Associates.

Tombaugh, T. N., Kozak, J., and Rees, L. (1996). Normative data for the controlled oral word association test. In O. Spreen and E. Strauss (Eds.), A compendium of neuropsychological tests: Administration, norms and commentary (2nd ed.). New York: Oxford.

Tucker, J. S., Burnam, A., Sherbourne, C. D., Kung, F. Y., and Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine, 114, 573–580.CrossRefPubMed

Turner, B. J., Laine, C., Cosler, L., and Hauck, W. W. (2003). Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. Journal of General Internal Medicine, 18, 248–257.CrossRefPubMed

Wagner, G. J. (2002). Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care and STDs, 16, 599–608.CrossRefPubMed

Wainberg, M. A., and Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. JAMA, 279, 1977–1983.CrossRefPubMed

Wall, T. L., Sorensen, J. L., Batki, S. L., Delucchi, K. L., London, J. A., and Chesney, M. A. (1995). Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug and Alcohol Dependence, 37, 261–269.CrossRefPubMed

Wechsler, D. (1997). Wechsler adult intelligence scale Manual (3rd ed.). New York: The Psychological Corporation.

Wilkie, F. L., Eisdorfer, C., Morgan, R., Loewenstein, D. A., and Szapocznik, J. (1990). Cognition in early human immunodeficiency virus infection. Archives of Neurology, 47, 433–440.PubMed

Wilkinson, G. S. (1993). The Wide Range Achievement Test Administration Manual (3rd ed.). Wilmington, DE: Wide Range.

Yeudall, L. T., Fromm, D., Reddon, J. R., and Stefanyk, W. O. (1986). Normative data stratified by age and sex for 12 neuropsychological tests. Journal of Clinical Psychology, 42, 918–946.CrossRef

Titel: Neurocognitive Aspects of Medication Adherence in HIV-Positive Injecting Drug Users
verfasst von: Drenna Waldrop-Valverde
Raymond L. Ownby
Frances L. Wilkie
Alison Mack
Mahendra Kumar
Lisa Metsch
Publikationsdatum: 01.05.2006
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 3/2006
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-005-9062-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2006

The Differential Impact of PTSD and Depression on HIV Disease Markers and Adherence to HAART in People Living with HIV

HIV Education Needs Among Sudanese Immigrants and Refugees in the Midwestern United States

The Influence of Power on HIV Risk Among Pregnant Women in Rural Haiti

Alcohol and Sexual HIV Risk Behavior Among Problem Drinking Men Who Have Sex With Men: An Event Level Analysis of Timeline Followback Data

Number of Risk Acts by Relationship Status and Partner Serostatus: Findings from the HIM Cohort of Homosexually Active Men in Sydney, Australia